Abstract | Helicases have major roles in genome maintenance by unwinding structured nucleic acids. Their prominence is marked by various cancers and genetic disorders that are linked to helicase defects. Although considerable effort has been made to understand the functions of DNA helicases that are important for genomic stability and cellular homeostasis, the complexity of the DNA damage response leaves us with unanswered questions regarding how helicase-dependent DNA repair pathways are regulated and coordinated with cell cycle checkpoints. Further studies may open the door to targeting helicases in order to improve cancer treatments based on DNA-damaging chemotherapy or radiation.
Helicases are classically defined as molecular motors that are able to couple nucleoside triphosphate (NTP) hydroly sis (typically of ATP) to the unwinding of polynucleic acids 1 (FIG. 1) . In doing so, the helicase translocates in a directionally specific manner (3ʹ to 5ʹ or 5ʹ to 3ʹ) along the strand it predominantly interacts with. DNA helicases are classified according to their amino acid sequence homol ogy in the ATPase/helicase core domain into two larger superfamilies, superfamily 1 (SF1) and SF2, and four smaller superfamilies 1 . Although DNA helicases are con ventionally known to unwind Bform duplex DNA, some can unwind alternative DNA structures or have special ized functions (FIG. 1) . There are an estimated 95 helicases or putative helicases (31 DNA helicases and 64 RNA heli cases) encoded by the human genome Chemical damage to DNA can perturb cellular repli cation and transcription, and is implicated in mutagen esis, cell lethality, carcinogenesis, ageing and neurological disorders. Helicasedependent DNA repair systems and DNA damage tolerance mechanisms exist to preserve the informational content and integrity of the genome and to permit timely and efficient replication. Advances in understanding mechanistic and structural aspects of helicase function (BOX 1) suggest new avenues of research for helicasetargeted drugs to combat cancer and other diseases. The importance of DNA helicases in virtually all aspects of nucleic acid metabolism cannot be over estimated and places them at the forefront of biomedical research into genetic disorders, ageing and cancer biol ogy. An important concept that governs all of helicase biology is the crucial role of protein-protein inter actions in helicase function to preserve genomic stability, and understanding these interactions is a central area for future research.
DNA helicases in genomic stability and cancer Helicasedependent mechanisms help cells to cope with endogenous or exogenous stress to prevent chromo somal instability and to maintain cellular homeostasis. Numerous genetic diseases that confer a predisposition to cancer are linked to mutations in genes encoding DNAhelicaselike proteins 4 (TABLE 1). The expression of many DNA helicases is upregulated in transformed or neoplastic cells and tissues [5] [6] [7] [8] and is required for cancer cell proliferation or resistance to DNA damage imposed by chemotherapy (TABLE 2) . Continuous upregulation of helicase gene expression in cancer reflects the need for an elevated DNA damage response to deal with rep licative lesions that arise in highly proliferative states. Conversely, chromosomal instability from loss of heli case functions in hereditary helicase disorders promotes carcinogenesis, thus implicating DNA helicases as a prominent class of genome caretakers.
The RecQ family. The five RecQ family DNA helicases (RECQL1, BLM, WRN, RECQL4 and RECQL5) are highly conserved and are required for genomic stabil ity 9, 10 . Three are implicated in genetic diseases that
Poikiloderma
A skin condition that consists of areas of increased and decreased pigmentation, prominent blood vessels and thinning of the skin.
Homologous recombination (HR).
A type of genetic recombination in which nucleotide sequences are exchanged between two similar or identical molecules of DNA. HR is most widely used by cells to accurately repair damage that involves both strands, such as double-strand breaks or interstrand DNA crosslinks.
Base-excision repair (BER) . A DNA repair pathway that operates on small DNA lesions such as oxidized or reduced bases, fragmented or non-bulky adducts, or those produced by methylating agents. The resulting single-strand break can be processed by either short-patch BER (through which a single nucleotide is replaced) or long-patch BER (through which 2-10 new nucleotides are synthesized).
Transcription Factor IIH (TFIIH).
A general transcription factor complex composed of multiple protein subunits that enables formation of the RNA polymerase II pre-initiation complex. TFIIH is also implicated in nucleotide-excision repair (NER).
Nucleotide-excision repair
(NER). This pathway recognizes bulky distortions in the DNA that occur after ultraviolet radiation or chemotherapy. Recognition of these distortions leads to the removal of a short single-stranded DNA segment that includes the lesion, creating a single-strand gap in the DNA, which is subsequently filled by a DNA polymerase.
predispose to cancer: BLM in Bloom syndrome 11 , WRN in Werner syndrome 12 and RECQL4 in Rothmund-Thomson syndrome (RTS). In addition, RECQL4 mutations are genetically linked to RAPADILINO syndrome and Baller-Gerold syndrome (BGS) [13] [14] [15] (TABLE 1) . Individuals affected by Bloom syndrome are diagnosed with a wide variety of cancer types earlier in life than the normal population. Patients with Werner syndrome display many features of premature ageing and frequently develop a broad range of neoplasias including thyroid epithelial tumours, malignant melanomas, menin giomas, softtissue sarcomas, haematological and lym phoid neoplasms, and osteosarcoma 16 . The three genetic disorders involving RECQL4 mutations show overlap ping clinical features and a broad range of severity, which is probably influenced by genetic or environmental fac tors. Individuals with RTS display growth retardation and photosensitivity with poikiloderma, hair thinning and loss, juvenile cataracts and a predisposition to osteogenic sarcomas. The range of tumour types in patients with RECQL4 mutations includes lymphomas, predominantly in patients with RAPADILINO syndrome 17 . RECQL4 has a crucial role in prostate carcinogenesis 7 . RECQL4 expression increases as a function of tumour grade; fur thermore, RECQL4 depletion was shown to dramati cally reduce the growth, survival and invasiveness of metastatic prostate cancer cells in vitro, and to decrease tumorigenicity in a mouse model 7 .
Although no genetic disorders have been linked to RECQL1 or RECQL5 mutations, these helicases are also likely to have important roles in cancer. RECQL1 poly morphisms are associated with the survival of patients with pancreatic cancer 18, 19 . Despite the absence of phe notypes in unstressed Recql1-knockout mice, primary embryonic fibroblasts from these mice display chro mosomal instability 20 . RECQL1depleted human cells display increased chromosomal instability 21 and sensi tivity to ionizing radiation 21 -which is consistent with involvement in doublestrand break (DSB) repair 22 -or agents that induce oxidative damage 23 or replica tion stress 24 (TABLE 2) . RECQL1 is highly expressed in various cancers, and its depletion reduces tumour cell proliferation 5, [25] [26] [27] [28] . RECQL5 is also required for cancer cell proliferation 29 . Moreover, Recql5deficient mice are highly cancerprone; approximately half of these cancers are lymphomas and the rest are solid tumours of differ ent tissue origins 30 . RECQL5 has roles in transcription through its interaction with RNA polymerase II and in DNA repair by regulating homologous recombination (HR) 30, 31 and base-excision repair (BER) 32 .
The Fe-S family. Conserved iron-sulphur (Fe-S) clus ters are found in metalloproteins that are implicated in DNA replication and repair 33 . Of the four human FeS DNA helicases (XPD, FANCJ (also known as BRIP1 and BACH1), RTEL1 and DDX11), all are implicated in autosomal recessive genetic diseases: XPD in xeroderma pigmentosum, Cockayne syndrome, trichothiodystro phy (TTD) and cerebrooculofacioskeletal (COFS) syndrome 34 ; FANCJ in Fanconi anaemia (FA) [35] [36] [37] ; DDX11 in Warsaw breakage syndrome (WABS) 38, 39 ; and regulator of telomere elongation helicase 1 (RTEL1) in dyskeratosis congenita [40] [41] [42] (TABLE 1) . XPD, which was originally discovered through its linkage to xero derma pigmentosum 43, 44 , encodes a helicase subunit of the transcription factor II H (TFIIH) complex that is implicated in basal transcription and nucleotide-excision repair (NER); recessive mutations in XPD result in dis eases with potentially related or overlapping clinical features 34 . The hallmark of xeroderma pigmentosum is severe sun sensitivity and predisposition to skin cancer. Although less common, individuals with XPD muta tions may display xeroderma pigmentosum combined with Cockayne syndrome, characterized by devel opmental and neurological abnormalities as well as ultraviolet light sensitivity, but not skin cancer.
Key points
• Helicase-dependent DNA damage response and repair mechanisms help cells to cope with endogenous or exogenous stress to prevent chromosomal instability and maintain cellular homeostasis.
• Inactivating mutations in DNA helicase genes are linked to genetic disorders that are frequently associated with various cancers. However, the expression of many DNA helicases is upregulated in transformed or neoplastic cells and tissues and is required for cancer cell proliferation or resistance to DNA damage imposed by chemotherapies.
• The RecQ and iron-sulphur (Fe-S) families of DNA helicases have prominent roles in the maintenance of genomic stability through their catalytic functions and protein interactions in telomere maintenance and DNA repair pathways including nucleotide-excision repair (NER), homologous recombination (HR)-mediated repair of double-strand breaks (DSBs), interstrand crosslink (ICL) repair, and base-excision repair (BER).
• Specialized DNA helicases efficiently unwind G-quadruplex (G4) DNA and other forms of alternative DNA structures such as telomeric displacement loops (T-loops). Emerging evidence suggests that DNA helicases that unwind non-conventional DNA structures have important roles in the replication or repair of telomeres.
• Replication forks in rapidly dividing cancer cells are likely to encounter DNA lesions that perturb fork progression.
Evidence suggests that certain DNA helicases help cells to cope with replicative lesions by remodelling the fork, restoring the integrity of broken replication forks, or having a role in the signalling mechanism for the intra-S-phase checkpoint.
• Elevated expression of DNA helicases in rapidly proliferating cells and tumours suggests that they have a role in resistance to DNA-damaging agents and may represent good biomarkers for response to chemotherapies.
• High-throughput screening of chemical libraries may prove to be beneficial for the discovery of small molecules that modulate helicase function in vivo. Such compounds may be useful in synthetic lethal approaches used in anticancer strategies that target tumours with existing DNA repair deficiencies. FA, arising from autosomal recessive mutations in FANCJ or in any of at least 14 other genes, is character ized by progressive bone marrow failure, acute myeloid leukaemia and other cancers 45 . In some cases, individu als with FA display congenital defects or developmental abnormalities that affect organ systems. All FAmutant cell lines are hypersensitive to DNAcrosslinking chemo therapies. FANCJ mutations are also associated with breast cancer, which is consistent with the physical inter action between FANCJ and BRCA1 and with the role of FANCJ as a tumour suppressor 46 . The FeS helicase RTEL1 is essential and has a dominant role in setting telomere length in mice 47 . Studies with Rtel1deficient mouse embryonic stem cells demonstrated that the helicase is required for DNA damage resistance and acts as an antirecombi nase in HR or counteracts telomeric G-quadruplex (G4) DNA structures 48 . RTEL1 knockdown in human cells renders them sensitive to the DNAcrosslinking agent mito mycin C (MMC) 49 . Genomewide association studies have identified RTEL1 as a susceptibility locus for human glioma [50] [51] [52] . Recently, germline mutations in RTEL1 were linked to dyskeratosis congenita [40] [41] [42] , which is characterized by inherited bone marrow failure and cancer predisposition.
Other human DNA helicases that are important for genomic stability. Other human DNA helicases have genome caretaker roles (TABLE 1) . XPB, which was first discovered by its genetic linkage to combined xeroderma pigmentosum and Cockayne syndrome 53, 54 , is a TFIIH component (like XPD) and is also implicated in xero derma pigmentosum with neurological abnormalities and in TTD 34 . Another DNA helicase, PIF1, suppresses apoptosis in human tumour cells 55 , and mutations are associated with breast cancer susceptibility 56 . Mutations in senataxin, which is a putative RNA/DNA helicase that is involved in transcription termination at RNA polymerase pause sites, are genetically linked to the neurodegenerative disorder ataxia with oculomotor apraxia 2 (AOA2) 57, 58 . Branch-migration of three-or four-stranded joint DNA molecules by a DNA helicase (for example, BLM, WRN or RECQL1) (f) can suppress or promote the formation of Holliday Junction (HJ) structures that can be resolved by specialized endonucleases to create crossover products that are responsible for loss of heterozygosity and cancer predisposition 214 . The BLM helicase, together with topoisomerase 3α (TOP3α) and RecQ-mediated genome instability 1 (RMI1) and RMI2, dissolves double HJ structures (g) during HR or at converging replication forks to generate non-crossover DNA molecules 215 . See the main text for details. 
Intra-S-phase checkpoint
Single-stranded DNA created at the stalled replication fork generates a signal mediated by phosphorylation of target proteins (for example, mammalian ATR) that prevents the cell cycle from progressing to the G2 phase until replication is complete.
DNA charge transport
The process of transporting electrons along the axis of a double helical DNA molecule through the overlapping π-orbitals of stacked DNA base pairs.
Slippage
When a helicase loses its firm grasp on single-stranded DNA, causing it to slide backwards owing to re-annealing of complementary strands at the DNA fork.
DNA2, which is a helicasenuclease that is involved in Okazaki fragment processing 59 , has prominent roles in DNA end resection during HRmediated repair and in mitochondrial DNA maintenance [60] [61] [62] . Mutations in the mitochondrial DNA helicase twinkle (also known as PEO1) cosegregate with several neuromuscular degen erative disorders 63 . The number of DNA helicases impli cated in cancer and other diseases is likely to grow.
Helicase functions in response to DNA damage The DNA damage response mediated by the intra-S-phase checkpoint and DNA repair pathways help cells to cope with a variety of chromosomal lesions that are major contributing factors to various forms of cancer. Helicases have unique roles in these pathways through fork remodelling, DNA damage recognition, damaged strand removal, and recombinationbased strategies to restore genomic integrity. The requirement for helicases to carry out roles in DNA repair through their catalytic functions or interactions with other proteins continues to be an important area of study.
Consequences of DNA lesions on helicase functions.
Recognition of DNA damage among billions of normal base pairs in the human genome is formidable. Many helicases (for example, WRN 64 ) preferentially bind and unwind forked DNA structures; therefore, they may arrive early at blocked replication forks to facilitate DNA damage recognition. Generally speaking, bulky covalent adducts inhibit helicasecatalysed DNA unwinding in a strandspecific manner; however, the type of adduct and/or helicase under investigation and its assembly in a protein complex is relevant 65 . FeS cluster DNA heli cases (for example, XPD) may collaborate with other DNA repair proteins that are able to carry out DNA charge transport to search for DNA damage 66 . Helicase partnerships with the heterotrimer replication pro tein A (RPA) 67 or other singlestranded DNA (ssDNA) binding proteins (for example, POT1) 68 enable them to unwind past certain DNA lesions. In some cases, repli cative helicases (and their associated replisomes) may bypass or hop over template lesions, thus providing the opportunity for ssDNA signalling mechanisms to medi ate DNAdamageinduced intraSphase checkpoints 69 .
XPD bypasses DNAbound proteins in vitro

70
; however, the physiological importance remains unclear.
DNA damage recognition by TFIIH helicases implicated in NER. NER relies on faithful recognition of bulky helixdistorting lesions and subsequent incisions upstream and downstream in the lesioncontaining strand 71 (FIG. 2a) . In order for this to occur, TFIIH must be recruited to the site of DNA damage. The multisubunit TFIIH complex possesses two oppositepolarity DNA heli cases, XPD (5ʹ to 3ʹ) and XPB (3ʹ to 5ʹ), which orches trate the opening of duplex DNA around the lesion and verify the distorting DNA damage 72 . Considerable efforts have been made to understand the precise roles of XPB, XPD and their protein partners in the various steps that are necessary for NER: TFIIH recruitment, duplex opening
Box 1 | Advances in understanding helicase mechanisms
In certain cases, helicase monomers efficiently translocate along single-stranded DNA (ssDNA) and/or unwind double-stranded DNA (dsDNA) (see the figure, parts a and b), whereas multimerization or functional cooperation between monomers promotes dsDNA unwinding or the displacement of proteins bound to DNA, represented by red boxes 196 (see the figure, parts c and d). The prototypical Escherichia coli RecQ helicase operates by an inchworm mechanism involving ATP-driven movements of two DNA-binding domains remaining in the same relative orientation along the DNA lattice 197, 198 . By contrast, the replicative bacterial (DnaB) or eukaryotic (minichromosome maintenance (MCM)) helicase forms a hexameric ring-like structure that unwinds dsDNA by steric exclusion 199 (see the figure, part e). Coordinate action of helicases with opposite polarities provides a unique dual-motor mechanism 89, 200 (see the figure, part f). A rolling model for unwinding by a helicase homodimer has also been proposed 201 . The efficiency of DNA translocation versus unwinding may be affected by mutations that uncouple catalytic activities 202, 203 or perturb oligomerization 204 . Certain helicases use their motor ATPase to disrupt protein-DNA interactions to enable smooth replication progression or to regulate homologous recombination (HR) by stripping RAD51 from DNA 205 . DNA helicases may act by repetitive movements on DNA 206, 207 . The Bloom syndrome helicase (BLM) was shown to unwind a single DNA duplex molecule, re-anneal it by strand switching, and re-initiate unwinding in successive cycles in a replication protein A (RPA)-dependent manner 208 . Helicase repetitive action may be important for remodelling stalled replication forks, displacing DNA-bound proteins, or preventing illegitimate recombination. This mechanism of action is quite distinct from a hexameric ring-shaped helicase that potentially regulates DNA unwinding during replication by ATP-induced slippage 209 . It remains to be shown if strand switching, repetitive unwinding, or slippage by a helicase occur in vivo.
Structural analyses of DNA helicases and their accessory domains (for example, human RECQ1 (REF. 210) and Thermoplasma acidophilum XPD 211 ) have provided molecular insights to their unwinding mechanisms and disease pathology. Analysis of disease-causing missense mutations in the context of domain structure has helped to explain the molecular basis for helicase dysfunction in DNA repair.
and damage verification. XPB ATPase (but not helicase) activity is required for TFIIH recruitment to DNA damage 72 . Damage recognition in NER involves a scan ning mechanism that is dependent on XPD helicase activity 73 . The ability of XPD to sense a DNA lesion during unidirectional ATPdependent translocation is required for DNA damage verification, which is necessary for NER 74 . Lesion verification also involves XPB. One model depicts XPB melting a modest 5 nucleotide (nt) gap and XPD unwinding 22 base pairs (bp) by 5ʹ to 3′ translocation up to the site of the lesion, thereby defin ing the characteristic size of the ssDNA bubble to be excised 75 . Further studies are required to understand how DNA damage recognition by TFIIHassociated helicases is coordinated with subsequent steps in NER. Furthermore, the effects of mutations or polymor phisms in the NER helicases on their catalytic func tions, protein interactions, disease pathology and cancer predisposition are of considerable interest 4, 76 . DNA helicases implicated in crosslink resistance and DSB repair. A DNA interstrand crosslink (ICL) is highly toxic and poses a strong block to cellular rep lication and transcription 77 . Reactive oxygen species from cellular biochemical processes may cause per oxidation of lipids, which in turn damage DNA to result in ICLs and other forms of oxidative DNA damage. Moreover, several DNAdamaging agents (for example, MMC and cisplatin) that are used for anticancer therapy induce DNA ICLs 77 . Thus, a comprehensive understand ing of the response to ICLs may provide diagnostic and therapeutic opportunities to combat cancer.
The FA pathway is a highly integrated protein net work that provides cellular resistance to DNA ICLs and other forms of replication stress 45 . Furthermore, it pro tects haematopoietic stem cells from endogenous alde hydes that produce DNA or protein crosslinks, thus ultimately suppressing bone marrow failure and leukae mia 78, 79 . The currently identified 15 FA gene products collaborate with other proteins that are involved in HR, NER and trans lesion synthesis to tolerate and repair DNA ICLs 77 (FIG. 2b) . The FA pathway helps to channel DSBs through HR in order to prevent an inappropriate engage ment of breaks by errorprone non-homologous end-joining (NHEJ) 80, 81 . FANCM and FANCJ operate at distinct steps of ICL repair. FANCM shares sequence homology with DNA helicases and can translocate along, but not unwind, duplex DNA 82 . It is a component of the FA core complex that is important for early ICL recognition, for stabiliz ing and remodelling the blocked replication fork through interaction with the histonefoldcontaining protein 
DDX11
DDX11-targeted siRNA caused mitotic failure and sister-chromatid cohesion defects in HeLa cells 227, 228 ; it also reduced proliferation and elevated chromosome segregation, telomere defects and apoptosis in melanoma cells 229 .
NR PIF1
PIF1-targeted siRNA reduced colony formation, increased sub-G1 DNA, and prolonged S phase in colon cancer cells , raising the interesting possibility of tar geting this protein interaction to sensitize cancer cells to chemotherapeutic agents that induce DNA ICLs.
Other helicases are involved in resistance to ICLs or other forms of replication stress. BLM resides in a multi protein nuclear complex with FA core complex proteins to recognize the DNA lesion and stabilize the stalled rep lication fork 85 . Together with the RecQmediated genome instability (RMI) subcomplex (RMI1 and RMI2) and topoisomerase 3α, BLM interacts with FANCM to help manage the repair of stalled replication forks through its ability to dissolve a double Holliday Junction (HJ) and related DNA structures 86 ; such repair is necessary to avoid loss of heterozygosity and to suppress the cancer that is observed in patients with Bloom syndrome 87, 88 . BLM also interacts with FANCJ to maintain chromo somal stability 89 . Therefore, BLM probably has upstream and downstream roles in ICL repair, including recogni tion of the ICL and strand resection of a DSB that arises from an unhooked ICL. FANCJ may also have a role in strand resection through its interaction with BLM and the MRN protein complex, which consists of MRE11-RAD50-Nijmegen breakage syndrome protein 1 (NBS1) and acts as a sensor of DSBs 90 . Cellular studies suggest that the WRN helicase, in conjunction with BRCA1, has a role in processing DNA ICLs 91 . WRN is required for ataxia telangiectasia mutated (ATM) activation and the intraSphase checkpoint in response to ICL induced DSBs 92 and other forms of fork arrest 93 . WABS causing DDX11 mutations render cells sensitive to the , XPE and RAD23B, the XPB and XPD helicases act with XPA to create a single-stranded bubble coated by replication protein A (RPA) that is processed by nucleases (the XPF-ERCC1 complex and XPG) to remove the damaged strand in NER 72, 75 . b | Multiple helicases are implicated in crosslink resistance pathways that intersect with the Fanconi anaemia (FA) pathway 77 . After lesion detection, nuclease-catalysed incisions on each side of the crosslink remove (unhook) it from one strand, leaving a small gap that converts the fork to a double-strand break (DSB). Parallel pathways resolve the lesion. For simplicity, the double replication fork model 216 is not shown. HR, homologous recombination; Pol, DNA polymerase; ssDNA, single-stranded DNA.
RAD51-double-stranded DNA filaments
During an early stage of homologous recombination, the major eukaryotic recombinase RAD51 forms nucleoprotein filaments on double-stranded DNA to initiate the homology search and exchange of DNA strands. Filaments can also occur on single-stranded DNA.
Synthetic lethality
Cell death resulting from the combined inactivation or inhibition of two genes or gene products that are non-lethal when inactivated individually. Synthetic lethality can occur between genes and small molecules, which may lead to anticancer therapies.
chemotherapeutics MMC or camptothecin 39 , suggesting that they disrupt ICL repair. Depletion of HELQ (also known as HEL308) in human endocervical cancer cells rendered them MMC sensitive and defective in HR 94 . HELQ was observed to disrupt RAD51-double-stranded DNA filaments. However, this filamentdisrupting activity was not dependent on ATP hydrolysis by HELQ 95 , leav ing doubt as to the importance of HELQ catalytic activ ity in downstream events of HR repair. Human HELQ was shown to localize to damaged replication forks and to preferentially unwind the lagging strand of synthetic replication fork structures 96 , suggesting a role in fork remodelling or replication restart.
It is difficult to comprehend how so many helicases coordinate their roles in ICL repair and possibly render certain tumours resistant to crosslinking drugs. A key nexus is BLM, which interacts with FA proteins and DNA repair factors to repair the damage that is associated with ICLs and other forms of replication stress. For example, BLM collaborates with the FA pathway during S phase to prevent, and during mitosis to resolve, sisterchromatid bridging at fragile sites, ultimately to avoid chromosomal breakage and aneuploidy 97, 98 . BLM and other helicases are involved in checkpoint signalling, strand resection and resolution of recombination intermediates during DSB repair of processed ICL DNA intermediates 99 . RECQL5 efficiently displaces RAD51 bound to DNA 100 , whereas BLM does so poorly 101 and requires RAD51 inactivation to disrupt joint Dloop molecules 102 , thus suggesting that RECQL5 has a more prominent role than BLM in regulating HR by RAD51 filament disassembly. Further studies should delineate specialized functions of DNA helicases in response to drugs that induce ICLs and other forms of replication stress and that are widely used to treat leukaemia and other cancers 77 . Processing of ICLs can lead to DSBs, which also arise at broken replication forks as a consequence of topo isomerase inhibitors that trap topoisomerase-DNA complexes 103 . Ionizing radiation or DNAdamaging agents can also lead to DNA breaks. The RecQ helicases, like numerous tumour suppressors, are implicated in HRmediated repair of DSBs during the S or G2 phases of the cell cycle 9, 99 (FIG. 3a) . HR is a highfidelity repair mechanism, whereas NHEJ, which is the other major pathway of DSB repair and which occurs throughout the cell cycle, is errorprone. WRN interacts with the Ku protein complex 104 and DNA ligase IV 105 , which are both implicated in NHEJ, but its precise role as a DNA helicase or exonuclease to trim DNA ends is still poorly understood. It may be that WRN facilitates an alterna tive form of NHEJ that is mediated by short (5-25 bp) microhomologous DNA sequences to align broken DNA ends, which contributes to the repair of DSBs in chronic myeloid leukaemia cells 106 . Studies in cell lines suggest that both helicase and exonuclease functions of WRN are necessary for optimal recombinational repair [107] [108] [109] . ICLinducing DNAdamaging agents are among the most widely used classes of chemotherapies 77 . Understanding the cellular response to ICLinduced DNA damage is a high priority in order to improve chemotherapeutic efficacy. Certain sporadic head and neck, lung, ovarian, cervical and haematological cancers are characterized by epigenetic silencing of wildtype FA gene expression 110 . It is estimated that 15% of all cancers harbour defects in the FA pathway, and loss of hetero zygosity in FA carriers may increase cancer risk later in life 45 . Therefore, a synthetic lethality approach to target DNA damage response proteins in tumours that are char acterized by a defective FA pathway should be evaluated. If FAdeficient tumours become reliant on WRN or other helicases to cope with ICLinduced strand breaks, it will be worthwhile to explore helicase inhibitors as a new class of anticancer therapy (discussed further below). 113 . In addition to PARP1, WRN interacts with other BER proteins, notably DNA polymeraseβ, apurinic/apyrimidinic endo nuclease 1 (APE1), and flap endonuclease 1 (FEN1) to promote longpatch BER 114 (FIG. 3b) . In addition, RECQL5depleted cells are sensitive to oxidative agents and accumulate endogenous damage, including strand breaks and 8oxoguanine 32 , which is consistent with elevated cancer incidence in Recql5deficient mice 30 . Mutations in MMR genes are linked to colorectal, endo metrial, gastric and urothelial cancers 115 ; however, no DNA helicase has been implicated in eukaryotic MMR, unlike the established role of the UvrD helicase in Escherichia coli MMR 116 . MMR proteins interact with WRN, BLM, RECQL1 and FANCJ, which may regulate the roles of these helicases in recombinational repair 117 . Interestingly, exo nuclease 1 (EXO1), the nuclease that is implicated in eukaryotic MMR, interacts with WRN 118 , RECQL1 (REF. 119 ) and BLM 61 , and the BLM-EXO1 interaction is important for DSB resection during HRmediated repair.
Helicases help cells to cope with endogenous
DNA helicases at replication forks DNA helicase proteins, which were previously thought to operate strictly in DNA repair or replication, are now known to have interwoven roles in both processes. Maintaining replication fork integrity in vivo is a chal lenging task that necessitates versatile strategies to cope with fork obstacles (FIG. 4) . The importance of helicase dependent pathways to deal with replication stress is becoming evident from cellular and biochemical studies.
Fork remodelling and checkpoint signalling by helicase proteins. Replication lesions are prominent in rapidly dividing cancer cells 120 , and persistent replication fork stalling leads to genomic instability. Therefore, under standing how cancer cells deal with such lesions will be informative for developing antitumor strategies. An intraSphase checkpoint helps to stabilize proteins at stalled replication forks, to curtail cell cycle progression and to invoke DNA repair pathways. The Saccharomyces cerevisiae RecQ helicase Sgs1, through its interaction with the Rpa70 (also known as Rpa1) subunit of the Rpa , has a crucial role in checkpoint signal ling by recruiting the kinase Rad53 to regions of ssDNA at stalled replication forks and facilitating subsequent Rad53 activation 122, 123 . Conservation of checkpoint acti vation mechanisms through RecQ protein interactions remains an area of active investigation that will yield new insights into helicase functions at stalled replica tion forks, the molecular pathology underlying RecQ helicase disorders and targeting DNA damage check points in cancer. For example, the human WRN and BLM RecQ helicases also interact with RPA70 through an aminoterminal acidic domain, which is required for stimulation of helicase activity 124 . WRN is required for normal replication fork progression after exposure to the DNAdamaging agent methylmethanesulphonate or the replication inhibitor hydroxyurea 125 (TABLE 2) . Both WRN and BLM may help cells to cope with stalled rep lication forks by remodelling DNA structures, as dem onstrated in vitro [126] [127] [128] (FIG. 4a,b) ; however, their precise roles require further investigation. RECQL1 was shown to have a role in the restart of reversed replication forks induced by the topoisomerase 1 inhibitor camptothecin, which is used as an anticancer drug 129 . Unlike RecQ helicases, human Fbox DNA helicase 1 (FBH1), in cooperation with the MUS81 nuclease 130 , promotes DNA breakage and apoptosis in response to replication stress, thus suggesting a role for FBH1 during chronic replication stress to suppress oncogenic transfor mation by eliminating genetically unstable transformed cells that have been overwhelmed by broken replication forks 131 . Alternatively, FBH1 may promote DNA breakage following replication stress to promote a constitutively high number of DNA ends that can enhance chromo somal rearrangements and promote tumour progression. This would be consistent with the characteristic replica tive trauma that transpires during oncogene activation. The role of FBH1 in carcinogenesis requires further study.
FANCJ helicase activity is required for timely pro gression through S phase 132 . FANCJ acts with DNA topoisomerase2binding protein TOPBP1 in early 
MCM replicative helicase
Sister-chromatid exchange (SCE). A crossing-over event between sister chromatids, leading to the exchange of homologous stretches of DNA sequence.
DNA replication checkpoint control after hydroxyurea induced replication stress, suggesting that their inter action enables RPA to load onto chromatin, which is a prerequisite for the activation of ataxia telangiectasia and Rad3related (ATR) and for the replication checkpoint mediated by checkpoint kinase 1 (CHK1) 133 . The FANCM DNA translocase is recruited to ICLblocked replication forks, where it suppresses sister-chromatid exchange (SCE) by remodelling DNA 134, 135 . SMARCAL1 (also known as HARP) -which is defective in the autosomal Tcell immunodeficiency disorder Schimke immuneosseous dysplasia -surveys replication forks and catalyses fork regression and HJ branch migration to preserve genome stability 136 . The ability of SMARCAL1 to anneal comple mentary strands coated by RPA 137 distinguishes it from classic DNA helicases (for example, human RecQ pro teins) in which RPA inhibits strand annealing. Helicase like proteins known as chromatin remodelling enzymes (which are distinct from helicases because they do not separate complementary strands) reconfigure nucleosome interactions by displacing or repositioning histone octam ers bound to duplex DNA and by exchanging histone vari ants 138 . Chromatin remodelling complexes -for example, the nucleosome remodelling and deacetylase (NuRD) complex, which contains a protein with an ATPase/ helicaselike domain -regulate transcriptional events that are important for oncogenesis and cancer progression 139 .
Collaboration between replicative and accessory helicases. Aside from druginduced replication stalling, cells must cope with natural barriers to replication, such as stable protein-DNA complexes or a replication fork converging with the transcriptional apparatus. Helicase dependent mechanisms exist to minimize these colli sions 140 (FIG. 4c) . If the fork collides with transcription complexes, accessory motors help to displace RNA poly merase from DNA to restore fork progression. Genetic evidence from E. coli suggests that replication fork reversal sets the stage for accessory helicases to enable replication restart 141 . It is unknown whether a similar arrangement exists in eukaryotes.
The atypical helicaserelated minichromosome main tenance 8 (MCM8) and MCM9 replication elongation proteins are required for efficient HRmediated DNA DSB repair 142, 143 . Although MCM9 is dispensable for DNA replication, the characterization of mice lacking Mcm9 demonstrated somatic chromosomal instability, embry onic germ cell depletion in both sexes and hepatocellular 126, 128 ), carry out fork regression to create a Holliday Junction (HJ)-like 'chicken-foot' DNA structure. Reverse branch-migration of the regressed fork by a helicase (for example, WRN 127 or RECQL1 (REF. 129)) potentially allows replication bypass of the lesion in a non-recombinogenic mode. b | The WRN 217 or BLM 218 helicases can stimulate flap endonuclease 1 (FEN1)-catalyzed cleavage of 5′ flap structures that might arise during lagging-strand synthesis. BLM stimulates FEN1-mediated cleavage on flaps with secondary 5′ flap structure 219 , and WRN is involved with DNA polymerase-δ in a hairpin repair pathway 220 . DNA replication helicase/ nuclease 2 (DNA2) also facilitates FEN1-mediated cleavage of 5′ flaps 221 . c | Based on evidence from studies of Escherichia coli replication 222 , accessory DNA helicases (blue triangle) may coordinate with a eukaryotic minichromosome maintenance (MCM) helicase complex (purple) and replication machinery to displace a protein (orange oval) bound to duplex DNA that impedes fork progression. Replication fork reversal has a role in bacterial replication restart 141 . Further studies are required to substantiate this model for eukaryotes. . It will be important to determine how the recombination functions of MCM paralogues bear on pathways that affect germline stem cell mainte nance and proliferation, fertility and cancer suppression.
Accessory DNA helicases facilitate replication fork progression when the forks encounter a protein-DNA complex such as an RNA polymerase, a DNA sequence that is prone to forming an alternative struc ture (for example, Gquadruplexes (see the next sec tion)), or RNA-DNA hybrids known as R loops 145 ). In Schizosaccharomyces pombe, the Pfh1 helicase is required for replisome fork progression through difficult toreplicate sequences 146 , or past protein-DNA obsta cles, to ensure chromosomal integrity 147 . By sequence ; indicated by the beige triangles) resolve T-loops to enable telomere replication or repair. Helicase deficiency by mutation or RNAi-mediated depletion results in the persistence of T-loops which can be nucleolytically cleaved, leading to telomere instability. A helicase inhibitor (purple circle) may prevent T-loop unwinding, thus resulting in telomere instability. b | ssDNA that arises at telomeres or during lagging-strand synthesis can form a G-quadruplex (G4). Certain human helicases with 5ʹ to 3′ polarity (RTEL, Fanconi anaemia complementation group J protein (FANCJ) and PIF1) or 3ʹ to 5′ polarity (WRN and the Bloom syndrome helicase (BLM)) may resolve G4 structures to enable replication or repair 149 . Helicase deficiency by mutation or RNAi-mediated depletion results in telomere fragility. A helicase inhibitor or G4-specific ligand (green circle) may prevent G4 resolution at telomeres or other G-rich genomic sequences. Telomere instability can lead to cellular senescence of rapidly dividing cancer cells. 
G4 ligand
A typically planar aromatic small molecule that preferentially binds G-quadruplex (G4) DNA with high affinity. There are also proteins that preferentially bind G4 DNA.
Shelterin complex
A six-protein complex that localizes to the terminal TTAGGG repeats of mammalian chromosome ends, enabling cells to distinguish their natural chromosome ends from DNA breaks. The shelterin complex represses DNA repair reactions and regulates telomerase-based telomere maintenance.
T-loops
The 3′ single-stranded telomere DNA overhang circles around and hybridizes to the complementary strand of the adjacent double-stranded DNA to create a displacement loop (D-loop) by displacing one of the strands. T-loops are stabilized by telomere-binding proteins.
homology, only one Pfh1 family helicase (PIF1) exists in human cells, raising interest in its role in DNA synthe sis at difficulttoreplicate sequences that may be sites of chromosomal fragility and markers or causative factors for cancer or disease.
Helicases at telomeres and G4 DNA Gquadruplexes, which are composed of planar stacks of four guanines interacting by Hoogsteen hydrogen bonds, have attracted considerable attention, and there is evidence that they form in vivo and affect nucleic acid metabolism 148 . Certain DNA helicases (for example, WRN, BLM, FANCJ and PIF1) unwind G4 DNA sub strates in vitro 149 . Evidence has emerged that helicase res olution of G4 DNA has important biological outcomes for telomeres (FIG. 5) and other Grich sequences.
Leading versus lagging strand G4 instability. S. cerevisiae Pif1 resolves G4 structures to preserve replication fork progression and suppress chromosomal breakage 150 . Pif1 inactivation specifically destabilized a Grich human sub telomeric CEB1 minisatellite inserted into a yeast chro mosome 151 , and exposure to a G4 ligand exacerbated CEB1 instability 152 . The CEB1 minisatellite was unstable only when the Grich strand served as a template for leading strand replication 153 . This was not predicted because the laggingstrand template is believed to have moreextensive ssDNA. Genomic instability in Caenorhabditis elegans due to mutation of the FeS helicase DOG1 is thought to be caused by structural blocks to laggingstrand syn thesis 154 . The 5ʹ to 3ʹ directionality of Pif1 (or FANCJ 155 ) is well suited for unwinding G4 structures by loading onto downstream ssDNA of the leadingstrand template; however, the helicase must be able to 'turn its shoulder' as it unwinds G4 to permit the replication machinery to move past the helicase and copy unwound Grich sequence. Division of labour among G4 helicases may be handled in unique ways depending on the G4 topol ogy or on the type of chromosomal Grich region (for example, a telomere) that is undergoing replication or repair, or in the case of promoter elements, undergoing transcription.
Roles of vertebrate helicases in telomere maintenance and G4 DNA metabolism. Human cells that are defi cient in FANCJ, but not FANCD2 or FANCA, are sensi tive to the G4 ligand telomestatin 155 , which is known to cause telomere instability 156 . Moreover, patientderived FANCJmutant cells accumulate deletions at genomic sequences that are predicted to form Gquadruplexes 157 .
These findings suggest a model in which FANCJ sup presses genomic instability by resolving Gquadruplexes to enable smooth replication fork progression. A major advance would be obtaining direct evidence of G4structure accumulation in FANCJdeficient cells.
The pronounced number of predicted Gquadruplexes in promoter regions suggests their involvement in tran scriptional regulation 158 . Fibroblasts from individuals with Werner syndrome or Bloom syndrome display upregu lated expression of genes that are enriched for predicted G4forming sequences 159 . In the absence of WRN or BLM, G4 structures may accumulate to exclude nucleo somes or other DNAbinding proteins that repress transcription; however, this hypothesis remains untested. Continuity of replicative DNA synthesis provides a mechanism for maintaining epigenetic memory by incor porating new histones and depositing parental histones with their characteristic posttranslational modifications near their original locations 160 . Perturbation of DNA syn thesis by DNA lesions or structured DNA such as G4 can be overcome by translesion polymerases (for example, REV1) 161 . FANCJ was shown to maintain epigenetic sta bility in chicken cells by collaborating independently with REV1 or the RecQ helicases WRN and BLM to replicate G4forming DNA sequences 162 . Furthermore, FANCJ counteracts chromatin compaction by enabling smooth fork progression 163 . Although functional interactions between WRN and DNA polymerases are reported 164, 165 , there is currently no direct evidence that FANCJ interacts with a DNA polymerase. Interaction of FANCJ with BLM might be relevant to the replication or repair of G4 DNA 89 . Both FANCJ and BLM are found at telomeres 166 , where they potentially resolve G4 structures to repress telomere fragility 167 (FIG. 5) . WRN is also found at telomeres and interacts with shelterin complex proteins that regulate WRN catalytic functions on telomeric Dloops (T-loops) 168 . ) have dysfunctional telomeres and chromosomal instability [169] [170] [171] , and exhibit premature ageing and tumours (osteocarcinomas and soft tissue sarcomas) that are typically observed in patients with Werner syndrome 169 . A role for human WRN in resolv ing telomeric G4 DNA was suggested by the observa tion that WRNdeficient cells are defective in replication of the telomeric Grich laggingstrand template 172 ; how ever, the WRN-FEN1 interaction may also have a role 173, 174 . Although there is no evidence for a role for FANCJ at tel omeres, the FA pathway can influence telomere attrition and telomere recombination 175, 176 . A moreprominent player in telomere metabolism is probably RTEL1, which controls telomere length in mice and is required for telo mere stability 47 and resistance to telomere fragility induced by the porphyrin G4 ligand TMPyP4 (REF. 48); however, direct evidence that RTEL1 catalytically unwinds G4 DNA substrates to preserve telomere integrity is lacking. Recently, germline mutations in RTEL1 were linked to the telomere and cancer disorder dyskeratosis congenita [40] [41] [42] . Cells from patients with dyskeratosis congenita harbour ing biallelic RTEL1 mutations display telomere shortening owing to defective Tloop resolution 42 .
Helicase-based biomarkers and therapeutics
The elevated expression of DNA helicases in rapidly pro liferating cells and tumours suggests they have a role in resistance to DNAdamaging agents and may represent good biomarkers for response to chemotherapies. In general, RecQ and other helicase genes are not mutated or silenced in an appreciable number of tumours, and expression is most often upregulated. Thus, RecQ and perhaps other helicases may be important 'survival' factors in many tumours. One reported exception was the epigenetic inactivation of WRN in colorectal cancers 177 . Studies that deplete helicases using RNA interference reinforce the idea that DNA helicases affect cancer cell proliferation and survival after chemotherapeutic DNA damage (TABLE 2) . Recently, a screen to detect predictors of cancer cell response to DNAdamaging agents identified a putative DNA and RNA helicase schlafen 11 (SLFN11) as a potential biomarker 178 . Inactivation of a single DNAdamage response gene (such as a helicase gene) may serve as a predictive biomarker for personalized cancer therapy 179 . Conventional anticancer therapies have relied on the administration of DNAdamaging chemotherapies or radiation; however, these approaches have drawbacks owing to cytotoxic effects on normal cells and the ability of tumours to become resistant 180 . Personalized medicine to combat cancer is entering an age in which therapies make use of existing tumour deficiencies in the DNA damage response, cell cycle checkpoint signalling or DNA repair pathways 179 . Synthetic lethality exploits pre existing DNA repair deficiencies to enable an inhibitor of a given DNA repair pathway to be effective at eliminating those tumours. One potential caveat is therapyrelated carcinogenesis that is driven by DNAdamageinduced genomic instability when DNA repair is compromised. Thus, further studies are required to elucidate the precise roles of DNA repair proteins to avoid secondary cancers.
The involvement of DNA helicases in the repair of endogenous DNA damage in rapidly dividing cells has prompted interest in their potential as therapeutic tar gets, following the path of inhibitors of the singlestrand break repair protein PARP1. A proofofprinciple for the synthetic lethal approach was made by the discovery that tumours that are deficient for BRCA1 or BRCA2, which are defective in HR, are highly sensitive to PARP inhibitors 181, 182 . Results from preclinical and clinical trials (Phase I and Phase II) with PARP inhibitors that potenti ate the cytotoxicity and antitumor effects of chemotherapy drugs or radiation suggest that tumours that are defective in other DNA repair pathways (such as NER or BER) may also be susceptible 179 . HRdefective tumours that are char acterized by a deficiency of a key DNA repair helicase may also be amenable to DNAdamaging chemotherapies 183 . 185 . Further investi gation, such as a recent study that identified a BLM inhibi tor 187 , is necessary to characterize helicasespecific small molecules, their mechanisms of action and their poten tial as therapeutic drugs. To achieve synthetic lethality, a helicase inhibitor should be successful in a genetic back ground that is defective in a key protein that is involved in HR or another repair pathway, checkpoint signalling, DNA replication or the cell cycle.
Small
Targeting G-quadruplexes to combat cancer. In approxi mately 90% of cancers, progressive shortening of chro mosomes by loss of telomeric DNA is counteracted by upregulated telomerase activity 188 . Inhibiting telo merase may be useful to combat cancer, and a number of telomerase inhibitors are in clinical trials 189 . There is growing interest in anticancer drugs that stabilize telo meric Gquadruplexes 190 . Understanding the roles of G4resolving DNA helicases may lead to new insights for the design of G4 ligands that block G4 helicases or related proteins, thereby interfering with telomere semiconservative replication or impeding telomerase catalysed elongation in cancer cells and causing them to senesce (FIG. 5) .
The G4 ligand telomestatin induces telomere desta bilization by perturbing the interaction of the shel terin protein POT1 with telomeres, thus resulting in apop tosis of cancer cells 191 . Similarly, the synthetic G4binding ligand pyridostatin inhibits the prolifera tion of numerous cancer cell lines and uncaps POT1 from telomeric ssDNA in fibrosarcoma cells to trig ger a DNA damage response 192 . Chromatin immuno precipitation followed by highthroughput sequencing (ChIP-seq) analysis of DNA sequences associated with the DNA damage marker γH2AX was used to search for pyridostatinstabilized Gquadruplexes in human cells that displayed replication and transcriptiondependent DNA lesions 193 . Fluorescently labelled pyridostatin, detected mainly at nontelomeric G4 foci, colocalized with human PIF1. Pyridostatin modulated the expres sion of genes with high G4forming potential, includ ing the protooncogene SRC. The prospect of targeting Gquadruplexes in gene promoters for anticancer ther apy prompts a greater understanding of helicases that are involved in gene regulation. G4 ligands that target promoter Gquadruplexes are in Phase I and Phase II clinical trials for cancer 158 . Pyridostatin analogues also cause telomere dysfunction, resulting in longterm growth arrest and senescence of cancer cells, suggesting a smallmolecule approach to target Gquadruplexes for anticancer therapy 194 (FIG. 4) .
Targeting helicases that resolve unusual DNA struc tures (such as Gquadruplexes and Tloops) found at telomeres is a possibility (FIG. 5) . In addition, RecQ heli cases have a role in the alternative lengthening of telomeres (ALT) pathway, which affects proliferation in 5-10% of tumours 195 . Characterization of small molecules that modulate helicase function in the ALT pathway may be valuable for devising strategies to treat ALTdependent tumours (for example, osteosarcomas) that are resistant to conventional anticancer therapies.
Concluding remarks
Helicases have crucial roles in DNA metabolism, and their clinical importance is evident from the discovery of links between helicase gene mutations and cancer predisposing diseases. The prominent role of helicases in the DNA damage response and cell proliferation has prompted researchers to investigate their molecular and cellular functions. However, there is still much to learn about the underlying mechanisms that are responsible for genomic instability when human DNA helicases are defective. This challenge is particularly daunting owing to the complex network of interconnected roles of DNA helicases and their protein interactions, which profoundly influence DNA repair and replication.
Continued interest in DNA repair as a target for anticancer strategies is propelling the field forwards to develop clinical applications for the diagnosis or treat ment of individuals that are predisposed to or experi encing cancer. As chemotherapy or radiation frequently introduces DNA damage, helicases that are involved in DNA repair are moving to the forefront of cancer research. To target helicasedependent processes, a greater understanding of the molecular and cellular functions of helicases will be required. Modulation of helicasemediated DNA damage response pathways to enhance anticancer efforts will require the develop ment of tumourtargeted genesilencing strategies and small molecules that bind to helicase proteins or their protein partners to alter catalytic functions and/or protein interactions. Wholegenome RNA interference screens should help to identify synthetic lethal relation ships of target helicases that may potentially be exploited to sensitize tumours by personalized medicine. The knowledge gained from mechanistic and structural stud ies of helicases (for example, BOX 1) and highthroughput screens to identify small molecules that directly bind to and modulate helicase function will hopefully result in translational advances. As we learn from the successes and limitations of the first wave of treatment strategies to target DNA damage response proteins, DNA helicases are now an important focus for understanding both the origins and treatment of human cancer.
